Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 10,000 shares at $8.85 ($89K) on 2022-12-15, disclosed to the SEC on 2022-12-19.
Open-market sale of $88k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |